Defence Therapeutics Inc. Tangible Net Worth Ratio
Defence Therapeutics Inc. tangible net worth ratio. Defence Therapeutics Inc. (DTC) has a Tangible Net Worth Ratio of 100.0% as of June 2023. This metric is calculated by deducting intangible assets (€0.00) from net assets (€1.57 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See DTC net asset quality score to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Defence Therapeutics Inc. (2020–2023)
Tangible net worth ratio of Defence Therapeutics Inc. from 2020 to 2023. This chart shows how Defence Therapeutics Inc.'s Tangible Net Worth Ratio has changed across 3 annual periods from 2020 to 2023. As of June 2023, the ratio stands at 100.0%, reflecting net assets of €1.57 Million with intangible assets of €0.00 EUR. See Defence Therapeutics Inc. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Defence Therapeutics Inc. Tangible Net Worth Ratio by Year (2020–2023)
Defence Therapeutics Inc. tangible net worth ratio by year from 2020 to 2023. The table below presents the year-by-year Tangible Net Worth Ratio for Defence Therapeutics Inc. from 2020 to 2023, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see DTC market cap overview.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 97.5% | €1.57 Million | €38.78K | €3.53 Million | ▼ -1.6 pp |
| 2021 | 99.2% | €5.49 Million | €46.02K | €5.61 Million | ▲ +1.6 pp |
| 2020 | 97.5% | €1.86 Million | €46.02K | €1.91 Million | — |